非骨水泥型全髋关节置换术治疗酒精性股骨头坏死

[目的]研究非骨水泥型全髋关节置换术治疗酒精性股骨头坏死的中期疗效.[方法]1997年3月～2002年6月,采用非骨水泥型全髋关节置换术治疗酒精性股骨头坏死41例(47髋),进行至少5年的随访、中期临床评估和影像学评估.临床评估以Harris评分为标准.影像学根据骨盆正位和髋关节侧位X线片,观察髋臼、股骨假体的位置以及周围骨质的改变.假体的生存率采用Kaplan-Meier分析,分别以股骨、髋臼假体的无菌性松动和任何原因所致的翻修为终点.[结果]得到至少5年随访的41例(47髋),术前Harris评分为42.4±6.4(24～49)分,最后1次随访评分为91.8±4.4(74～100)分.至最后1次随访时无1例翻修或表现为影像学无菌性松动,2髋出现骨盆局灶性骨溶解,6髋出现股骨局灶性骨溶解.Kaplan-Meier分析假体的生存率1.0(95%可信区间,0.98～1.0).[结论]非骨水泥型全髋关节置换术可为晚期酒精性股骨头坏死患者提供良好的中期临床效果.由于假体磨损、假体周围骨溶解等潜在因素,长期效果需要进一步随访.     

混合型全髋关节置换术治疗股骨头缺血性坏死中期评估

目的回顾性研究混合型全髋关节置换术（total hip arthroplasty，THA）治疗股骨头缺血性坏死的疗效及其影响因素。方法1998年1月至2001年6月，对采用同一类型混合假体行THA的股骨头缺血性坏死患者57例（61髋）进行至少6．5年的影像及临床随访。观察髋臼、股骨假体的位置及其周围的骨质改变，并测量臼杯内衬的磨损速度与磨损方向。假体的生存率采用Kaplan—Meier分析，分别以髋臼、股骨假体的无菌性松动和任何原因所致的翻修为终点。结果患者Harris评分从术前平均（39．0±6．0）分（25～56分），提高到末次随访时平均（90．4±4．6）分（80-100分）。截至末次随访时，1髋（2％）出现骨盆局灶性骨溶解，拟行植骨治疗；7髋（11％）出现股骨局灶性骨溶解。聚乙烯内衬平均线性磨损率为（0．14±0．05）mm／年（0．02-0．45mm／年）。Kaplan-Meier生存分析表明，以任何原因导致的翻修或再手术为终点，髋臼与股骨假体的生存率分别为98％（95％置信区间，0．96-1．00）和100％（95％置信区间，0．95-1．00），以假体无菌性影像学松动为终点，髋臼与股骨假体的生存率均为100％（95％置信区间，0．95-1．00）。结论应用混合型假体行THA可以为晚期股骨头缺血性坏死患者提供完好的中期固定及临床效果。然而，由于聚乙烯磨损、骨溶解等潜在危险因素的存在，长期效果仍须进一步随访。     

混合型初次全髋关节置换术中骨水泥柄10年以上的随访研究

目的回顾性分析混合型初次全髋关节置换术（THA）中骨水泥柄的临床和影像学疗效及其相关影响因素。方法对1999年1月至2001年12月期间接受混合型初次THA治疗髋部疾病的患者126例（135髋）进行至少10年的随访。观察Harris评分、股骨假体位置、骨水泥壳及其周围骨质变化。假体生存率采用Kaplan-Meier方法进行分析,以无菌性松动导致翻修及单纯骨溶解病灶清除植骨术为随访终点。结果共有79例（85髋）获得10年以上随访。Harris评分由术前（44.5±18.8）分提高至末次随访时（92.1±5.6）分。截至随访终点,在Gruen 1区观察到2髋发生骨溶解,7区4髋发生骨溶解现象。共有4例（4髋）接受翻修手术,其中1例男性患者因骨溶解致髋臼假体松动,同侧股骨近端骨溶解,同期行右髋臼侧翻修及股骨侧骨溶解病灶清除植骨术。另3例因髋臼假体松动行髋臼侧翻修术,影像学及术中见股骨假体稳定。以无菌性松动为随访终点,股骨假体生存率为100%;以无菌性松动翻修、单纯骨溶解病灶清除植骨术为随访终点,股骨假体生存率为98.8%（95%可信区间,12.23~12.32）。结论混合型初次THA术中骨水泥假体的远期生存率令人满意;采用第3代骨水泥技术固定的股骨柄取得与现代非骨水泥假体柄相近的远期生存率。     

非骨水泥全髋关节置换术治疗股骨头缺血性坏死的疗效观察

[目的]对使用非骨水泥全髋关节置换术治疗股骨头缺血性坏死的患者进行临床及影像学随访,探讨其疗效、并发症及其影响因素。[方法]选取2000年3月~2007年11月以来因股骨头缺血性坏死在本院行非骨水泥全髋关节置换术并具有完整临床及影像资料的76例(91髋)患者进行随访。临床随访包括术前术后Harris评分及各种并发症。影像学评估包括双侧髋关节正位、患髋侧位片,判断股骨及髋臼假体的位置及其周围骨质的变化,并测量髋臼内衬线性磨损量。[结果]截至末次随访时,68例(82髋)获得随访,随访率为90.1%,随访时间平均为48.8个月。术前Harris评分平均为42分(5~86分),末次随访时为93分(53~99分),优良率为90.2%。术后1例患者发生与活动相关的大腿痛,影像学上9髋股骨假体发生早期不稳定,14髋发生应力遮挡,5髋发生异位骨化。无假体松动或翻修病例。[结论]非骨水泥全髋关节置换术治疗晚期股骨头缺血性坏死疗效确切,但存在一过性大腿痛、应力遮挡、异位骨化、假体磨损等并发症,故需长期随访。     

全髋关节置换术治疗成人髋关节发育不良继发骨关节炎五年以上随访研究

目的 评价全髋关节置换术(total hip arthroplasty,THA)在成人髋关节发育不良(develop-mental dysplasia of the hip,DDH)继发骨关节炎患者中的疗效,回顾性分析该类患者THA术后5年以上的临床疗效及其影响因素.方法 对2000年2月至2002年7月在我院采用THA治疗DDH继发骨关节炎的患者55例(69髋)进行术后随访.临床评估以Harris评分为标准.影像学评估根据随访骨盆平片及患髋正、侧位X线片,观察髋臼、股骨假体位置及其周围骨质变化,测量内衬磨损率.假体生存率采用Kaplan-Meier方法进行分析,以任何原因的臼杯、股骨柄翻修或影像学假体明显松动为随访终点.结果 截至随访终点,共45例(57)髋获得5年以上随访,平均随访时间69个月,随访率为81.8%.Harris评分由术前的(46.19±18.01)分提高至末次随访时的(91.78±3.52)分,尚无假体翻修病例.聚乙烯内衬平均磨损率为(0.27±0.14)mm/年.5髋髋臼侧发生骨溶解,8髋股骨侧近端发生骨溶解.Kaplan-Meier分析假体总生存率为1.0(95%可信区间,0.98～1.00).结论 THA治疗DDH继发骨关节炎5年以上随访的影像学表现及临床效果尚可,但存在较高的聚乙烯磨损率及骨溶解发生率,对于年轻、活动量大的DDH患者,THA手术时应选择新型耐摩擦界面假体.DDH患者的定期随访尤为重要,可甲期发现骨溶解,及时给予相应的治疗.     

病灶清除颗粒骨植骨治疗全髋关节置换术后髋臼周围骨溶解

目的 探讨全髋关节置换（THA)术后髋臼周围骨溶解的治疗方法及疗效.方法 对24例(24髋)THA术后髋臼周围骨溶解行骨溶解病灶清除、同种异体颗粒骨植骨、更换高交联聚乙烯内衬和股骨头假体.14例（14髋）髋臼杯稳定保留金属臼杯;2例（2髋）髋臼杯稳定卡环损坏,被迫取出稳定臼杯,行非骨水泥型髋臼杯翻修术;8例（8髋）髋臼杯松动行髋臼翻修术.采用Harris评分评价髋关节功能.通过X线片观察假体是否松动和移植骨愈合情况.结果 23例获得随访,1例失访,平均随访16个月（10～45个月）.Harris评分由术前(58±23)分（17～86分）,提高到末次随访时(92±12)分（80～98分）,差异有统计学意义(P＜0.05).术后无感染、脱位、静脉血栓形成等.X线片显示髋臼假体无松动和异位骨化,可见移植骨-宿主骨交界处有连续性骨小梁通过.结论 保留髋臼杯积极进行骨溶解病灶清除,同种异体颗粒骨植骨,更换聚乙烯内衬和股骨头假体可阻断骨溶解的进展;髋臼翻修,同种异体颗粒骨植骨,短期随访示移植骨愈合、髋臼杯稳定,临床效果满意.     

病灶清除植骨保留髋臼假体的翻修术治疗假体周围局灶性骨溶解

目的 探讨病灶清除植骨保留髋臼假体的翻修术治疗全髋关节置换(total hip arthroplasty,THA)术后稳定固定的髋臼假体周围局灶性骨溶解的疗效.方法 2006年3月至2009年3月,THA术后髋臼假体稳定固定的假体周围局灶性骨溶解患者23例(23髋),男13例,女10例;年龄39～54岁,平均46.6岁.23例均为非骨水泥髋臼.初次THA至诊断髋臼假体周围骨溶解的时间为4.6～7.4年,平均5.5年.术前HarTis髋关节评分74分.手术经腹股沟入路,行髂骨内板开窗,清除髋臼骨溶解病灶、同种异体颗粒骨植骨;经后外侧人路更换聚乙烯内衬、股骨头假体,保留髋臼假体.翻修术后1、3、6、12个月及之后每年随访1次,以髋关节Harris评分评价临床疗效,摄X线片、CT扫描观察植骨区愈合、新发骨溶解病灶及假体移位情况.结果 16例获得随访,随访时间8～38个月,平均28个月.末次随访时Harris髋关节评分86～100分,平均93.8分.16例植骨区成骨均良好,12例植骨区完全被周围骨爬行替代,髋臼假体固定好,无髋臼假体松动及移位,无新发髋臼假体周围骨溶解,无异位骨化、脱位、深静脉血栓形成及感染等并发症.结论 清除病灶植骨、保留髋臼假体、更换聚乙烯内衬和股骨头假体的翻修术可有效减少聚乙烯磨损颗粒产生,避免骨溶解病灶进展导致的假体松动,近期随访结果良好.     

比较人工全髋关节置换在治疗股骨头缺血性坏死和类风湿性关节炎中的作用

目的评估人工全髋关节置换（THA）在治疗股骨头缺血性坏死（AVN）和类风湿性关节炎（RA）中的作用。方法采用非骨水泥型THA治疗的42例（50髋）AVN和40例（50髋）RA患者,分别进行临床和影像学比较。临床随访包括Harris评分、术后翻修率和并发症分析;影像学评估包括骨溶解、聚乙烯臼杯磨损率分析。结果患者均获随访,时间5～10年。临床随访结果：AVN组和RA组Harris评分由术前（49.59±9.03）分和（48.76±7.61）分,术后分别提高到（90.76±5.64）分和（87.18±6.83）分,较术前均明显提高,但两组间Harris分值提高差异无统计学意义（P〉0.05）;AVN组和RA组术后翻修率分别为6%（3髋）和8%（4髋）,并发症分别为6%（3髋）和10%（5髋）,两组间差异无显著性（P〉0.05）。影像学结果：聚乙烯磨损率AVN组明显高于RA组,分别为（0.15±0.11）mm/年和（0.10±0.09）mm/年,两组比较差异有统计学意义（P〈0.05）;髋臼侧骨溶解发生率AVN组明显高于RA组,分别为18%（9髋）和4%（2髋）,两组比较差异有统计学意义（P〈0.05）;而股骨侧假体骨溶解发生率分别为20%和12%,两组比较差异无统计学意义（P〉0.05）。结论非骨水泥型THA在AVN和RA随访中均取得了良好的疗效,但AVN组髋臼侧聚乙烯内衬磨损和髋臼骨溶解高于RA组。     

陶瓷对陶瓷全髋关节置换术治疗髋关节终末期疾病中长期疗效

[目的]评估陶瓷对陶瓷全髋关节置换术(THA)治疗髋关节终末期疾病中长期临床疗效和影像学结果,重点观察磨损、骨溶解、陶瓷碎裂发生率。[方法]2001年5月²005年5月,共142例(148髋)在本院行陶瓷对陶瓷THA治疗。平均年龄57.2岁(232005年5月,共142例(148髋)在本院行陶瓷对陶瓷THA治疗。平均年龄57.2岁(23⁸1岁),平均随访8.8年(781岁),平均随访8.8年(7¹2年)。术前诊断:股骨头缺血性坏死77髋(52%)、髋关节退行性骨性关节炎36髋(24.3%)、股骨颈骨折18髋(12.2%)、类风湿关节炎15髋(10.1%)及化脓性髋关节继发关节退变2髋(1.4%)。评估患者术后临床功能(Harris评分)、术后大腿及腹股沟疼痛发生率。影像学评估重点观察是否有磨损、假体周围骨溶解及陶瓷碎裂。[结果]平均Harris评分由术前的58.3分(1012年)。术前诊断:股骨头缺血性坏死77髋(52%)、髋关节退行性骨性关节炎36髋(24.3%)、股骨颈骨折18髋(12.2%)、类风湿关节炎15髋(10.1%)及化脓性髋关节继发关节退变2髋(1.4%)。评估患者术后临床功能(Harris评分)、术后大腿及腹股沟疼痛发生率。影像学评估重点观察是否有磨损、假体周围骨溶解及陶瓷碎裂。[结果]平均Harris评分由术前的58.3分(10⁷3分)提高到末次随访的92.5分(7973分)提高到末次随访的92.5分(79¹00分)。在末次随访时,有4髋(2.7%)出现腹股沟部疼痛,6髋(4.2%)出现大腿疼痛,这些患者均未发现股骨柄假体松动。共29髋观察到假体周围有非连续性透亮线,其中股骨侧25髋(16.9%),髋臼侧4髋(2.7%)。观察到膜内成骨在股骨侧有95髋(64.2%),在髋臼侧有88髋(59.5%)。股骨侧和髋臼侧均未观察到骨溶解。有2髋(1.4%)出现髋臼杯倾斜角的改变,2髋(1.4%)髋关节脱位,1髋(0.7%)陶瓷头碎裂,1髋(0.7%)出现异响。Kaplan-Meier生存率分析,假体平均术后8.8年存留率为98.1%。[结论]陶瓷对陶瓷THA是治疗髋关节终末期疾病的有效方法,可以获得满意的中长期临床疗效以及较高的假体存留率。     

保留股骨侧假体的髋关节翻修的临床疗效评析

目的探讨在髋关节翻修中保留股骨侧假体、单纯行髋臼侧翻修的短中期疗效。方法对2005年2月至2013年1月间采用保留股骨侧假体、单纯行髋臼侧假体翻修的31例31髋进行回顾性分析,其中男17例,女14例;年龄48~77岁,平均(64.32±8.76)岁。髋臼侧内衬磨损、无菌性松动、移位26例,髋关节脱位3例,髋臼骨折2例。股骨侧采用骨水泥固定的12例,生物固定的19例。进行翻修手术距离初次手术3个月~13年,平均(56.65±40.19)个月。18例翻修用髋臼与股骨侧假体保持同一厂家,13例因产品原因更换厂家。术中常规先行股骨侧假体稳定性的测试,评估股骨侧假体位置,对于股骨近端存在骨溶解的病例,溶解骨清理后进行打压植骨,单纯行髋臼侧翻修,采用Harris评分和X线片对其临床效果进行评估。结果术后随访12~103个月,平均(53.94±22.89)个月,Harris评分由翻修前平均(40.29±7.88)分增加至术后平均(86.42±5.2)分。所有患者无感染及关节脱位,未见假体移位,没有再翻修病例。结论全髋翻修中,根据患者年龄情况、股骨侧假体的固定情况、骨溶解的情况、初次置换假体选择情况、初次置换与翻修手术间隔时间情况,对部分患者采用保留股骨侧假体、单纯行髋臼侧翻修,可减少手术创伤,短中期随访效果满意。     

维生素D受体在糖尿病肾病足细胞损伤及蛋白尿缓解中的作用

目的探讨维生素D受体(VDR)在糖尿病肾病(DKD)足细胞中的表达水平及在足细胞损伤及蛋白尿缓解中的作用。方法(1)本研究纳入了65例诊断患有2型糖尿病(伴或不伴蛋白尿)的患者,并纳入了25例年龄和性别相匹配的健康体检者为对照组。根据白蛋白/肌酐(ACR)的尿排泄比例对2型糖尿病患者进行分组,分别为无蛋白尿(ACR<30 mg/g,n=24)、微量白蛋白尿(ACR 30~300 mg/g,n=18)和临床蛋白尿(ACR>300 mg/g,n=23)。另选择25例经肾活检确诊的DKD患者作为DKD组。正常肾脏组织标本均取自泌尿外科同一时期肾脏肿瘤切除患者10例。将各组检测指标进行对比,同时采用实时定量PCR、ELISA法和免疫组化法检测VDR在各组患者的血液、尿液样本和肾脏组织中的表达情况,以及使用Pearson相关分析分析VDR与尿蛋白的相关性。(2)在2型糖尿病肾病小鼠模型中对上述结果进行验证,将遗传背景均为C57BLKs/J的雄性db/db小鼠及同窝出生的db/m小鼠,随机分为正常对照组(A组)、DKD对照组(B组)、DKD二甲基亚砜处理组(C组)、DKD帕立骨化醇(VDR激动剂)处理组(D组),C、D组连续腹腔注射处理8周,对照组不做任何处理。小鼠10周龄时开始连续干预8周,在小鼠22周龄(开始干预后12周)检测各组小鼠体重、血、尿生化指标对比;Western印迹法检测β⁃catenin、VDR的变化;免疫荧光观察足细胞标志蛋白podocin及足细胞损伤蛋白α⁃SMA的表达变化。结果(1)与正常健康对照组相比,无蛋白尿组、微量白蛋白尿组和临床蛋白尿组的糖尿病患者血浆中VDR的mRNA和蛋白水平均较低(均P<0.05);与无蛋白尿组的糖尿病患者相比,微量白蛋白尿组和临床蛋白尿组的糖尿病患者血浆中VDR的mRNA和蛋白水平均较低(均P<0.05)。(2)与正常健康对照组相比,无蛋白尿糖尿病组和DKD组患者血浆中VDR的mRNA和蛋白水平均较低(均P<0.05);与无蛋白尿糖尿病组患者相比,DKD组患者血浆中VDR的mRNA和蛋白水平亦较低(均P<0.05)。(3)免疫组化结果显示,DKD组肾组织中VDR的表达明显少于正常对照组。(4)DKD患者血浆中VDR mRNA相对水平与ACR呈负相关(r=-0.342,P<0.05)。(5)各组尿液上清液中VDR的水平与血浆中的水平呈相反趋势。(6)Western印迹结果显示,B组、C组肾小球足细胞β⁃catenin蛋白表达高于D组(均P<0.05),VDR蛋白的表达低于D组(均P<0.05);免疫荧光结果显示,B组、C组肾小球足细胞podocin的表达低于D组(均P<0.05),α⁃SMA的表达高于D组(均P<0.05)。结论VDR高表达缓解DKD足细胞损伤及蛋白尿。     

Anterior Interosseous Nerve Palsy After Shoulder Arthroscopy Treated With Surgical Decompression: A Case Series and Systematic Review of the Literature

Background: Anterior interosseous nerve (AIN) palsy is a very uncommon cause of upper extremity pain and weakness that comprises less than 1% of all upper extremity nerve palsies. Rarely reported but also mentioned in the literature is AIN palsy after shoulder arthroscopy. Methods: A systematic review of the literature to date using PubMed was conducted to identify patients who suffered AIN palsy after shoulder arthroscopy procedures. Articles included met the following criteria: (1) published in English; (2) primary presentation of the data; (3) patients had undergone shoulder arthroscopy before developing symptoms of AIN palsy; and (4) diagnosis was confirmed with clinical symptoms of AIN palsy. Measured outcomes included patient demographics, specific shoulder procedure, anesthesia procedure, intra-operative patient positioning, intra-operative compressive dressing, intra-operative traction, surgical versus conservative treatment, abnormal findings during decompression procedure, proposed mechanism of injury, and follow-up. Results: The search yielded 6 articles, of which 4 (13 cases) met inclusion criteria. An additional 2 cases were included in this report totaling 15 cases. The average patient age was 49 years (range: 31-64) with 73% males. At average follow-up of 24 months, 67% of patients experienced complete resolution of symptoms—more than half of which underwent surgical decompression. Patients who failed to progress experienced weakness of the flexor digitorum profundus and flexor pollicis longus muscles. Conclusions: Proposed injury mechanisms for AIN palsy after shoulder arthroscopy range from mechanical trauma, compressive hematoma, and direct anesthetic neurotoxicity. Management should be directed by clinical symptoms, imaging, and patient factors with majority of patients expected to have excellent clinical outcomes.     

不同尿钙水平的Gitelman综合征患者临床特点比较

目的观察不同尿钙水平Gitelman综合征(GS)患者的临床特点,探讨尿钙在GS疾病临床分型中的价值。方法收集2016—2018年来自中国国家罕见病注册系统(NRSC)、在北京协和医院行SLC12A3基因检测诊断为GS患者的临床资料,分析其尿钙特点,比较不同尿钙水平患者的临床和实验室检查指标。氢氯噻嗪试验按照标准操作流程进行,测定患者基线和用药后3 h内氯离子排泄分数改变量的最大值(ΔFECl)。结果共有83例GS患者被纳入研究,其中低尿钙患者53例(63.86%)。低尿钙组尿钙/肌酐比明显低于非低尿钙组[(0.085±0.058)mmol/mmol比(0.471±0.284)mmol/mmol,t=7.349,P<0.001]。两组患者在年龄、性别、估算肾小球滤过率、血压、血尿电解质水平、代谢性碱中毒方面差异均无统计学意义。低尿钙组患者乏力(χ2=4.595,P=0.032)及多尿(χ2=5.778,P=0.016)发生比例低于非低尿钙组,两组患者在其他临床症状方面差异无统计学意义。低尿钙和非低尿钙组各有16例患者行氢氯噻嗪试验,中位ΔFECl结果分别为0.539%(0.430%,1.283%)和0.829%(0.119%,1.298%),均提示对氢氯噻嗪无反应,组间差异无统计学意义(U=130.000,P=0.956)。结论GS患者中低尿钙比例为63.86%,尿钙水平与疾病临床表型、NCC功能损伤严重程度之间均无明确相关性。     

Fibrinogen-thrombin collagen patch reinforcement of highrisk colonic anastomoses in rats

AIM To evaluate the effectiveness of human fibrinogenthrombin collagen patch(TachoSil~?) in the reinforcement of high-risk colon anastomoses.METHODS A quasi-experimental study was conducted in Wistar rats(n = 56) that all underwent high-risk anastomoses(anastomosis with only two sutures) after colectomies. The rats were divided into two randomized groups: Control group(24 rats) and treatment group(24 rats). In the treatment group, high-risk anastomosis was reinforced with TachoSil~? (a piece of Tacho Sil? was applied over this high-risk anastomosis, covering the gap). Leak incidence, overall survival, intra-abdominal adhesions, and histologic healing of anastomoses were analyzed. Survivors were divided into two subgroups and euthanized at 15 and 30 d after intervention in order to analyze the adhesions and histologic changes. RESULTS Overall survival was 71.4% and 57.14% in the TachoSil~? group and control group, respectively(P = 0.29); four rats died from other causes and six rats in the treatment group and 10 in the control group experienced colonic leakage(P 0.05). The intra-abdominal adhesion score was similar in both groups, with no differences between subgroups. We found non-significant differences in the healing process according to the histologic score used in both groups(P = 0.066).CONCLUSION In our study, the use of TachoSil~? was associated with a non-statistically significant reduction in the rate of leakage in high-risk anastomoses. TachoSil~? has been shown to be a safe product because it does not affect the histologic healing process or increase intra-abdominal adhesions.     

Role of Conventional and Diffusion-Weighted Magnetic Resonance Imaging of Spinal Treatment Protocol for Hydatid Disease

Objective:

To demonstrate the role of magnetic resonance imaging (MRI) in determining the treatment protocol for hydatid disease of the spine.

Design:

Case report; literature review.

Findings:

Diffusion-weighted MRI can help differentiate complicated infected hydatidosis from abscesses, epidermoid cysts from arachnoid cysts, and benign from malignant vertebral compression fractures. It is also helpful in differentiating between abscesses and necrotic tumors.

Conclusion:

Diffusion-weighted MRI can help differentiate between infections requiring immediate surgery and those that can be treated medically with antihelmintic treatment.     

Fluorescence in the Sclera,Nails, and Teeth Secondary to Favipiravir Use for COVID-19 Infections

Favipiravir, an antiviral agent originally used for influenza infections, has become popular due to its beneficial signals in coronavirus disease. It is currently used in some countries within COVID-19 treatment protocols. This is an initial report of favipiravir-related fluorescence observed in three healthcare providers working in the same ward in our hospital. All three individuals had been diagnosed with COVID-19 two months earlier and were treated with favipiravir. None of the three individuals received hydroxychloroquine or tetracyclines. Wood’s light examination led to an incidental discovery of favipiravir-induced fluorescence involving the sclera, nails, and teeth. In all patients, white linear, square, and band-like specks of fluorescence were noticed on the sclera of both eyes, some teeth, and the proximal part of all fingernails and toenails. Exposure of the eyes to the Wood’s light was for a brief duration of 3 to 5 seconds during examination and photodocumentation. Favipiravir might cause bright white fluorescence of nails, sclera, and teeth, detectable by Wood’s light even two months after its cessation.     

Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers

BACKGROUND: Sugammadex rapidly reverses rocuronium- and vecuronium-induced neuromuscular block. To investigate the effect of combination of sugammadex and rocuronium or vecuronium on QT interval, it would be preferable to avoid the interference of anaesthesia. Therefore, this pilot study was performed to investigate the safety, tolerability, and plasma pharmacokinetics of single i.v. doses of sugammadex administered simultaneously with rocuronium or vecuronium to anaesthetized and non-anaesthetized healthy volunteers. METHODS: In this phase I study, 12 subjects were anaesthetized with propofol/remifentanil and received sugammadex 16, 20, or 32 mg kg(-1) combined with rocuronium 1.2 mg kg(-1) or vecuronium 0.1 mg kg(-1); four subjects were not anaesthetized and received sugammadex 32 mg kg(-1) with rocuronium 1.2 mg kg(-1) or vecuronium 0.1 mg kg(-1) (n=2 per treatment). Neuromuscular function was assessed by TOF-Watch SX monitoring in anaesthetized subjects and by clinical tests in non-anaesthetized volunteers. Sugammadex, rocuronium, and vecuronium plasma concentrations were measured at several time points. RESULTS: No serious adverse events (AEs) were reported. Fourteen subjects reported 23 AEs after study drug administration. Episodes of mild headache, tiredness, cold feeling (application site), dry mouth, oral discomfort, nausea, increased aspartate aminotransferase and gamma-glutamyltransferase levels, and moderate injection site irritation were considered as possibly related to the study drug. The ECG and vital signs showed no clinically relevant changes. Rocuronium/vecuronium plasma concentrations declined faster than those of sugammadex. CONCLUSIONS: Single-dose administration of sugammadex 16, 20, or 32 mg kg(-1) in combination with rocuronium 1.2 mg kg(-1) or vecuronium 0.1 mg kg(-1) was well tolerated with no clinical evidence of residual neuromuscular block, confirming that these combinations can safely be administered simultaneously to non-anaesthetized subjects. Rocuronium and vecuronium plasma concentrations decreased faster than those of sugammadex, reducing the theoretical risk of neuromuscular block developing over time.     

血浆凝血因子VIII水平与IgA肾病患者临床病理改变及预后的关系

目的探讨血浆凝血因子VIII(factor VIII,FVIII)水平与IgA肾病(IgAN)患者临床参数及预后的关系。方法收集2016年1月至2016年12月中南大学湘雅二医院确诊的IgAN患者的临床资料。按照时间依赖的受试者工作特征曲线(ROC)得出的血浆FVIII预测IgAN预后的临界值,将患者分为高FVIII组(FVIII>140.50%)和低FVIII组(FVIII≤140.50%),比较两组患者肾活检时基线临床参数的差异。以估算肾小球滤过率(eGFR)下降≥30%或进入终末期肾脏病(ESRD)为终点事件,采用Kaplan-Meier生存曲线及Cox回归方程法分析血浆FVIII水平对IgAN患者预后的影响。结果共93例IgAN患者纳入本研究,中位随访时间为35.15(33.77,36.76)个月,12例(12.90%)患者发生终点事件。高FVIII组患者年龄、血肌酐、尿素氮、血三酰甘油、血总胆固醇、血浆纤维蛋白原、D-二聚体、24 h尿蛋白量、蛋白C、蛋白S和eGFR下降速率高于低FVIII组(均P<0.05);eGFR、血白蛋白、中位随访时间低于低FVIII组(均P<0.05)。Kaplan-Meier生存分析结果显示,与低FVIII组比较,高FVIII组患者肾脏累积生存率降低(χ2=5.635,P=0.018)。在校正收缩压、eGFR、尿蛋白、肾小管萎缩/间质纤维化程度等因素后,多因素Cox回归分析结果显示,高血浆FVIII水平是IgAN患者肾脏预后不良的独立危险因素(HR=4.147,95%CI 1.055~16.308,P=0.042)。结论血浆FVIII水平与IgAN患者临床指标及预后相关,高血浆FVIII水平是IgAN患者肾脏预后不良的独立危险因素。     

罗伊适应模式对腹股沟疝无张力疝修补术后恢复情况的影响

目的探讨罗伊适应模式对患者腹股沟疝无张力疝修补术后恢复情况的影响。 方法将2016年1月至2019年5月在秦皇岛市第二医院择期进行无张力修补术治疗的120例腹股沟疝患者，按照随机数字法分为对照组和观察组，每组各60例。对照组采用常规护理治疗，观察组在对照组的基础上采用罗伊适应模式。比较2组患者的术后临床指标、心理状态、围手术期并发症发生情况及满意度。 结果术后观察组患者的首次排气时间、恢复正常饮食时间、离床活动时间和术后住院时间均低于对照组（P<0.05）；术后观察组患者的抑郁自评量表（SDS）和焦虑自评量表（SAS）评分显著低于对照组（P<0.05）；术后2组患者均无切口感染发生，2组患者尿潴留、急性疼痛、认知功能障碍、发热、血肿等发生率相比无统计学差异（P>0.05）；术后观察组患者护理满意度为96.67%，显著高于对照组的83.33%（P<0.05）。 结论在常规护理的基础上，罗伊适应模式用于患者腹股沟疝无张力修补围手术期，能有效改善术后患者的焦虑/抑郁情绪，不增加围手术期并发症，促进术后患者的恢复及提高治疗满意度。     

Factors Associated With Reoperation After Silicone Proximal Interphalangeal Joint Arthroplasty

Background: Silicone proximal interphalangeal (PIP) joint arthroplasty has a high revision rate. It has been suggested that persistent ulnar deviation and joint instability influence the durability of PIP silicone arthroplasties. The goal of this study was to evaluate what factors are associated with reoperation after silicone PIP arthroplasty. Methods: We retrospectively evaluated all adult patients who underwent PIP silicone arthroplasty between 2002 and 2016 at one institutional system for inflammatory-, posttraumatic-, and primary degenerative arthritis. After manual chart review, we included 91 patients who underwent 114 arthroplasties. Fingers operated included 14 index, 41 middle, 38 ring, and 21 small fingers. Results: The overall reoperation rate was 14% (n = 16). Non-Caucasian race (P = .040), smoking (P = .022) and PIP silicone arthroplasty for post-traumatic osteoarthritis (P = .021) were associated with reoperation. The 1-, 5- and 10-year implant survival rates were 87%, 85%, and 85%, respectively. Conclusion: Caution should be exercised when considering PIP silicone arthroplasty of the index finger or in patients with post-traumatic osteoarthritis. It may be worthwhile addressing smoking behavior before pursuing silicone PIP arthroplasty.